Background: After a hematopoietic stem cell transplantation (HSCT), patients are left with little to no immunity to prevent infections. Importantly, this includes immunity gained from previous exposures, including vaccinations. This loss of immunity is a direct result of previous chemotherapy, radiation, and conditioning regimens the patients receive. It is critical to revaccinate patients post-HSCT to ensure protective immunity against vaccine-preventable diseases. Before 2017, all patients at our institution were referred to their pediatrician at approximately 12-month post-HSCT to be revaccinated. Clinical concern was raised at our institution regarding nonadherence and errors in vaccine schedules. Methods: To understand the magnitude of the problem with revaccination, we performed an internal audit of post-vaccine adherence in patients who received an HSCT between 2015 and 2017. A multidisciplinary team was developed to review the audit results and make recommendations. Results: This audit revealed delays in the initiation of the vaccine schedule, incomplete adherence to the recommended revaccination schedule, and errors in administration. Discussion: Based on the review of the data, the multidisciplinary team recommended an approach for systematic assessment of vaccine readiness and centralization of the administration of vaccines to be done within the stem cell transplant outpatient center.
BuninN.SmallT.SzabolcsP.BakerK. S.PulsipherM. A.TorgersonT. (2012). NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Persistent immune deficiency in pediatric transplant survivors. Biology of Blood and Marrow Transplantation, 18(1), 6–15. https://doi.org/10.1016/j.bbmt.2011.11.014
2.
Freedman, J. L., Reilly, A. F., Powell, S. C., Bailey, L. C. (2015). Quality improvement initiative to increase influenza vaccination in pediatric cancer patients. Pediatrics, 135(2), e540-6.
3.
Gouveia-AlvesF.GouveiaR.GinaniV. C.SeberA.KuramotoD. A.MuradG. F.SpinaF. G.PetrilliA. S.ZecchinV. G.GranatoC.CarlesseF.de Moraes-PintoM. I. (2018). Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center. Transplant Infectious Disease, 20(4), Article e12903. https://doi.org/10.1111/tid.12903
4.
HudspethM. P.HillT. N.LewisJ. A.Van MeterE.RagucciD. (2010). Post-hematopoietic stem cell transplant immunization practices in the Pediatric Blood and Marrow Transplant Consortium. Pediatric Blood & Cancer, 54(7), 970–975. https://doi.org/10.1002/pbc.22444
5.
JohnM. J.MathewA.BhatS.PrabhakaranA.GeorgeB.JohnJ. (2018). Post stem cell transplantation revaccination: A survey of the current practices in India. Vaccine, 36(16), 2176–2180. https://doi.org/10.1016/j.vaccine.2018.02.084
6.
PatelS. R.ChisholmJ. C.HeathP. T. (2008). Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation. Pediatric Clinics of North America, 55(1), 169–186. https://doi.org/10.1016/j.pcl.2007.10.012
7.
RosatiC.LehmannL. (2016). Increasing vaccination compliance in the pediatric hematopoietic stem cell transplant population. Biology of Blood and Marrow Transplantation, 22(3), S433–S434. https://doi.org/10.1016/j.bbmt.2015.11.991
8.
SilvaP. M. D.SilvaL. M. D.SimioniA. J.SouzaM. P. D.ColturatoV. A. R.MachadoC. M. (2017). Difficulties in the revaccination program of hematopoietic stem cell transplantation recipients. Revista do Instituto de Medicina Tropical de São Paulo, 59, Article e69. https://doi.org/10.1590/s1678-9946201759069
9.
TordaA.AlexanderJ. (2009). Revaccination of bone marrow transplant recipients: A review of current practices in Australia. Internal Medicine Journal, 39(4), 216–221. https://doi.org/10.1111/j.1445-5994.2009.01698.x
10.
TsangV. (2012). Vaccination recommendations for the hematology and oncology and post-stem cell transplant populations. Journal of the Advanced Practitioner in Oncology, 3(2), 71–83. https://doi.org/10.6004/jadpro.2012.3.2.2
